CC
MDSO

Claybrook Capital’s Medidata Solutions, Inc. MDSO Stock Holding History

Claybrook Capital’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-327
Closed -$22K – 781
2018
Q4 		$22K Buy
+327
New +$23.1K 0.01% 345

Other funds holding MDSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Claybrook Capital's MDSO Position: Q1 2019 in Review

Claybrook Capital sold out of Medidata Solutions, Inc. (MDSO) in Q1 2019, closing a stake of 327 shares — an estimated $22K sold.

Claybrook Capital first reported a position in MDSO in Q4 2018 and held it in 1 quarter. The position peaked at $22K in Q4 2018. 285 funds tracked by Wall St. Rank hold MDSO as of Q1 2019.

  • Claybrook Capital reported no remaining Medidata Solutions, Inc. position as of Q1 2019 after selling out during the quarter.
  • Claybrook Capital sold 327 Medidata Solutions, Inc. shares in Q1 2019, an estimated $22K.
  • Claybrook Capital first reported a position in Medidata Solutions, Inc. in Q4 2018 and held it in 1 quarter.
  • Claybrook Capital's Medidata Solutions, Inc. position peaked at $22K in Q4 2018.
  • 285 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.